Literature DB >> 27102489

Trained immunity: A program of innate immune memory in health and disease.

Mihai G Netea1, Leo A B Joosten2, Eicke Latz3, Kingston H G Mills4, Gioacchino Natoli5, Hendrik G Stunnenberg6, Luke A J O'Neill4, Ramnik J Xavier7.   

Abstract

The general view that only adaptive immunity can build immunological memory has recently been challenged. In organisms lacking adaptive immunity, as well as in mammals, the innate immune system can mount resistance to reinfection, a phenomenon termed "trained immunity" or "innate immune memory." Trained immunity is orchestrated by epigenetic reprogramming, broadly defined as sustained changes in gene expression and cell physiology that do not involve permanent genetic changes such as mutations and recombination, which are essential for adaptive immunity. The discovery of trained immunity may open the door for novel vaccine approaches, new therapeutic strategies for the treatment of immune deficiency states, and modulation of exaggerated inflammation in autoinflammatory diseases.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27102489      PMCID: PMC5087274          DOI: 10.1126/science.aaf1098

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  111 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 2.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

Review 3.  Macrophage receptors implicated in the "adaptive" form of innate immunity.

Authors:  D M E Bowdish; M S Loffredo; S Mukhopadhyay; Alberto Mantovani; S Gordon
Journal:  Microbes Infect       Date:  2007-09-14       Impact factor: 2.700

4.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

5.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 6.  Peptidoglycan recognition proteins: on and off switches for innate immunity.

Authors:  Håkan Steiner
Journal:  Immunol Rev       Date:  2004-04       Impact factor: 12.988

7.  Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.

Authors:  Deborah W Hendricks; Henry H Balfour; Samantha K Dunmire; David O Schmeling; Kristin A Hogquist; Lewis L Lanier
Journal:  J Immunol       Date:  2014-04-16       Impact factor: 5.422

8.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  β-Glucan derived from Aureobasidium pullulans is effective for the prevention of influenza in mice.

Authors:  Daisuke Muramatsu; Atsushi Iwai; Shiho Aoki; Hirohumi Uchiyama; Koji Kawata; Yosuke Nakayama; Yasuhiro Nikawa; Kisato Kusano; Mitsuyasu Okabe; Tadaaki Miyazaki
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more
  717 in total

1.  Targeting of Formyl Peptide Receptor 2 for in vivo imaging of acute vascular inflammation.

Authors:  Tamara Boltersdorf; Junaid Ansari; Elena Y Senchenkova; Jieny Groeper; Denise Pajonczyk; Shantel A Vital; Gaganpreet Kaur; J Steve Alexander; Thomas Vogl; Ursula Rescher; Nicholas J Long; Felicity N E Gavins
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

Review 2.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 3.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 4.  Genome-Wide Approaches to Defining Macrophage Identity and Function.

Authors:  Gregory J Fonseca; Jason S Seidman; Christopher K Glass
Journal:  Microbiol Spectr       Date:  2016-10

Review 5.  Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 6.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 7.  Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity.

Authors:  Anthony T Phan; Ananda W Goldrath; Christopher K Glass
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

8.  Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness.

Authors:  Ettore Crimi; Giuditta Benincasa; Silvia Cirri; Rebecca Mutesi; Mario Faenza; Claudio Napoli
Journal:  Epigenetics       Date:  2020-04-14       Impact factor: 4.528

Review 9.  Evolutionary and population (epi)genetics of immunity to infection.

Authors:  Luis B Barreiro; Lluis Quintana-Murci
Journal:  Hum Genet       Date:  2020-04-13       Impact factor: 4.132

Review 10.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.